The 1 Thing I'll be Looking for in Novavax's Earnings Report

Investors are breathing a sigh of relief ahead of Novavax's (NASDAQ: NVAX) earnings report tomorrow. That's because it looks like the worst-case scenario isn't going to happen. The concern? That Novavax would delay regulatory requests for its coronavirus vaccine candidate once again. The company already postponed requests more than once due to manufacturing issues.

But the good news has begun flooding in over the past few days. Novavax has completed regulatory filings in multiple countries. The company also told Reuters that it has resolved all of its manufacturing problems and doesn't expect any related roadblocks. Now, we can look ahead to the earnings report with a bit more optimism. So, what should we look for? Well, there's one thing in particular that I'm eager to hear about...

Image source: Getty Images.

Source Fool.com